Consolidated Statements of Cash Flows (Unaudited) - USD ($)	12 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Cash Flows From Operating Activities:
Net income	$ 3,902,406	$ 3,408,783
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	601,433	633,854
Stock compensation expense	551,881	588,984
Bad debt expense	510,000	465,050
Decrease (increase) in:
Trade receivables	312,283	(4,180,558)
Long-term receivables, prepaids and other assets	(383,703)	854,239
Increase (decrease) in:
Accounts payable	(960,140)	924,947
Accrued liabilities	462,194	(500,253)
Deferred revenue	(417,499)	(15,560)
Net cash provided by operating activities	4,578,855	2,179,486
Cash Flows From Investing Activities:
Purchase of property and equipment	(1,447,880)	(204,005)
Capitalization of software costs	0	(111,241)
Sale of long-term investments	477,884	0
Net cash used in investing activities	(969,996)	(315,246)
Cash Flows From Financing Activities:
Proceeds from employee stock purchase plans	0	244,417
Proceeds from exercise of options and warrants	164,997	666,903
Proceeds from issuance of notes payable	1,268,959	56,078
Net increase in lines of credit	1,430,000	380,000
Redemption of Series B-1 Preferred	0	(999,990)
Dividends paid	(439,833)	(782,123)
Common stock buy-back	(482,406)	0
Payments on notes payable and capital leases	(1,833,592)	(591,092)
Net cash provided by (used in) financing activities	108,125	(1,025,807)
Net increase in cash and cash equivalents	3,716,984	838,433
Cash and cash equivalents at beginning of period	14,892,439	14,054,006
Cash and cash equivalents at end of period	18,609,423	14,892,439
Supplemental Disclosure of Cash Flow Information:
Cash paid for income taxes	76,063	75,714
Cash paid for interest	146,889	166,888
Supplemental Disclosure of Non-Cash Investing and Financing Activities:
Preferred stock to pay accrued liabilities	0	200,000
Common stock to pay accrued liabilities	514,286	1,048,710
Dividends accrued on preferred stock	$ 586,443	$ 573,532